slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 7,621-7,650
Pages 2,605
Rows per page 30
Component
7,621-7,650 of 78,129
14
Includes footnote regarding mid-quarter divestiture impact and CAGR calculation period.Etsy | Results Presentation Deck | 35 slides · Etsy
Conference presentation Investor relations Beat · Satisfaction3 hits
16
The slide uses a combination of bar charts and trend lines to demonstrate operational efficiency and investment outcomes.Etsy | Results Presentation Deck | 35 slides · Etsy
Conference presentation Investor relations 3 hits
34
Includes guidance horizon markers for FY23PF to FY25e.Eutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 3 hits
59
Includes a heatmap showing synergy scores across cell lines and two dose-response line charts showing increased inhibition in combination.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 3 hits
15
Includes a heatmap showing synergy scores and two dose-response line charts demonstrating enhanced inhibition in combination treatments.Exscientia | Results Presentation Deck | 24 slides · Exscientia
Conference presentation Investor relations Beat · Evidence3 hits
10
Includes a disclaimer about GAAP/non-GAAP reconciliation.FGI Industries | Investor Presentation Deck | 15 slides · FGI Industries
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction3 hits
25
The slide uses a donut chart for the overall mix and stacked bar charts for historical revenue trends.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
30
Slide 30 of a presentation.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
31
Heartland Financial USA | Results Presentation Deck | 55 slidesHeartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
32
The slide provides a snapshot of the CRE-NOO portfolio performance and composition as of 3Q 2023.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
34
The slide uses a mix of bar charts and pie charts to illustrate portfolio composition and performance metrics.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
35
HTLF branding present. Data covers 3Q 2022 to 3Q 2023.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
40
The slide uses a waterfall chart for the credit loss allowance and a stacked bar chart for the allowance percentage trends.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action3 hits
06
The slide uses a combination of a bar chart for quarterly comparison, a line chart for LTM trend, and a donut chart for backlog composition.Hexagon Purus | Investor Presentation Deck | 33 slides · Hexagon Purus
Conference presentation Investor relations Beat · Solution3 hits
17
The slide uses three horizontal stacked bar charts to visualize revenue distribution.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Solution3 hits
93
Hugo Boss | Investor Presentation Deck | 104 slidesHugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations 3 hits
94
Hugo Boss | Investor Presentation Deck | 104 slidesHugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations 3 hits
16
Includes comparative bar charts for transduction efficiency and toxicity markers, and flow cytometry data for anti-exhaustion.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · Competitive AnalysisLoop · Golden Circle3 hits
35
Includes a complex biological pathway diagram and three supporting charts demonstrating efficacy.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle3 hits
45
Slide presents three distinct preclinical data sets: survival in STS mice, tumor response in STS mice, and survival in KPC pancreatic cancer mice.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle3 hits
48
Includes waterfall and spider/line plots for patient response data.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle3 hits
15
Includes comparative data charts for transduction efficiency and signaling, and flow cytometry data for anti-exhaustion.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire3 hits
39
Includes scientific diagrams of molecular pathways and bar/line charts showing efficacy data.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
40
Slide presents three distinct preclinical data sets: survival in STS, tumor response in STS, and survival in KPC pancreatic cancer models.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
42
Includes both internal unpublished data and external reference data from Winograd et al. (2015).Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
44
Includes spider plots/swimmer-style plots for tumor response and bar charts for best percentage change.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action3 hits
16
Includes comparative data points for transduction efficiency and experimental data for signaling and exhaustion.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
40
Includes scientific diagrams of molecular pathways, penetration depth charts, and efficacy metrics.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
41
Slide contains three distinct charts comparing IMX-110 against standard of care in mouse models.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits
45
The slide compares sarcoma patients against non-sarcoma patients using line charts for lesion size change and a bar chart for best percentage change.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 3 hits